Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on July 10, 2018, 10:25:06 am

Title: Those Treated With Newer Hep C Drugs Have Lower Non-Liver Cancer Rates
Post by: Hep Editors on July 10, 2018, 10:25:06 am

Among people with hepatitis C virus (HCV), those treated with interferon have a higher rate of non-liver cancers than those treated with interferon-free direct-acting antiviral (DAA) regimens, InfoHep reports.

Presenting their findings at the 52nd International Liver Congress in Paris, researchers from Gilead Sciences analyzed data on 367,156 people with hep C whom they identified through U.S. health insurance claims databases. Then they used insurance claims information to determine the type of hep C treatment these individuals received, if any, and whether they were diagnosed with any cancers.

For more...
https://www.hepmag.com/article/treated-newer-hep-c-drugs-lower-nonliver-cancer-rates